Artículos por temáticas

Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials

Jia Q, Deng Y, Qing H.

Biomed Res Int. 2014;2014:837157. doi: 10.1155/2014/837157. Epub 2014 Jul 17.

In-house heart-brain clinics to reduce Alzheimer's disease incidence

de la Torre JC.

J Alzheimers Dis. 2014;42 Suppl 4:S431-42. doi: 10.3233/JAD-141560.

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease

Talbot K, Wang HY.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S12-25. doi: 10.1016/j.jalz.2013.12.007.

Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease

Bennett DA, Yu L, De Jager PL.

Biochem Pharmacol. 2014 Apr 15;88(4):617-30. doi: 10.1016/j.bcp.2014.01.037. Epub 2014 Feb 6.

A systematic review on natural medicines for the prevention and treatment of Alzheimer's disease with meta-analyses of intervention effect of ginkgo

Yang M, Xu DD, Zhang Y, Liu X, Hoeven R, Cho WC.

Am J Chin Med. 2014;42(3):505-21. doi: 10.1142/S0192415X14500335.

Arginine metabolising enzymes as targets against Alzheimers' disease

Whiteley CG.

Neurochem Int. 2014 Feb;67:23-31. doi: 10.1016/j.neuint.2014.01.013. Epub 2014 Feb 4.

From the editor

Garner JD.

J Women Aging. 2014;26(1):1-2. doi: 10.1080/08952841.2013.815562.

Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation issues, and preliminary efficacy

Cheng ST, Lau RW, Mak EP, Ng NS, Lam LC.

Gerontologist. 2014 Dec;54(6):1049-58. doi: 10.1093/geront/gnu018. Epub 2014 Mar 31.

Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease

Miroddi M, Navarra M, Quattropani MC, Calapai F, Gangemi S, Calapai G.

CNS Neurosci Ther. 2014 Jun;20(6):485-95. doi: 10.1111/cns.12270. Epub 2014 Apr 10.

Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease

Ponnayyan Sulochana S, Sharma K, Mullangi R, Sukumaran SK.

Biomed Chromatogr. 2014 Nov;28(11):1431-90. doi: 10.1002/bmc.3116. Epub 2014 Feb 11.

Advances in quantitative structure-activity relationship models of anti-Alzheimer's agents

Ambure P, Roy K.

Expert Opin Drug Discov. 2014 Jun;9(6):697-723. doi: 10.1517/17460441.2014.909404. Epub 2014 Apr 23.

Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders

Farías GA, Guzmán-Martínez L, Delgado C, Maccioni RB.

J Alzheimers Dis. 2014;42(2):357-67. doi: 10.3233/JAD-132741.

Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease

Carman AJ, Dacks PA, Lane RF, Shineman DW, Fillit HM.

J Nutr Health Aging. 2014 Apr;18(4):383-92. doi: 10.1007/s12603-014-0021-7.

Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside

Fan X, Sun D, Tang X, Cai Y, Yin ZQ, Xu H.

Med Res Rev. 2014 Sep;34(5):957-78. doi: 10.1002/med.21309. Epub 2014 Feb 5.

Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

Li MM, Yu JT, Wang HF, Jiang T, Wang J, Meng XF, Tan CC, Wang C, Tan L.

Curr Alzheimer Res. 2014;11(9):844-52.